Sazan Anwar
Associate, Stockholm
Corporate Advisory, Equity Capital Markets, Public M&A
Contact
Sazan Anwar is a Stockholm-based Associate and a member of Roschier’s Public M&A, Equity Capital Markets and Corporate Advisory practices. She joined Roschier in 2023.
Work highlights
Sazan Anwar’s experience includes advising:
- CVC in the recommended cash offer for Resurs Holding;
- A bid consortium consisting of Greenoaks and Long Path in their recommended public offer for Karnov;
- Avalara in its SEK 7.3 billion public offer for Pagero;
- TA Associates in the fully underwritten SEK 4.3 billion rights issue in Elos Medtech;
- Frazier Life Sciences in its investment in Egetis Therapeutics.
Career
Roschier (2023-)
Education
Örebro University, LL.M. (2023)
Languages
English, Kurdish, Swedish, Turkish